2 terminated, 1 completed. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Keming Gao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Project Guard: Reducing Alcohol Misuse/Abuse in the National Guard Smartphone brief intervention (SP-BI), Enhanced Usual Care (EUC) - Alcohol Use | Not applicable | Completed | Keming Gao | 850 | 2017-03-01 | 2021-09-29 |
| Gao NARASD Lithium Study Lithium - Bipolar Disorder | Phase 4 | Terminated | Keming Gao | 24 | 2016-09-01 | 2020-07-10 |
| Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder Quetiapine XR, Placebo - Major Depressive Disorder, Generalized Anxiety Disorder | Phase 3 | Terminated | Keming Gao | 23 | 2008-06-01 | 2016-12-29 |
Alcohol Drinking (1) · Bipolar Disorder (1) · Depressive Disorder, Major (1) · Generalized Anxiety Disorder (1)
Lithium (1) · Quetiapine Fumarate (1)
United States (3)